C

Curaleaf Holdings Inc
CNSX:CURA

Watchlist Manager
Curaleaf Holdings Inc
CNSX:CURA
Watchlist
Price: 6.59 CAD 0.15%
Market Cap: 4.8B CAD
Have any thoughts about
Curaleaf Holdings Inc?
Write Note

Income Statement

Earnings Waterfall
Curaleaf Holdings Inc

Revenue
2.3B USD
Cost of Revenue
-1.3B USD
Gross Profit
1B USD
Operating Expenses
-1B USD
Operating Income
12.2m USD
Other Expenses
-600.3m USD
Net Income
-588.1m USD

Income Statement
Curaleaf Holdings Inc

Rotate your device to view
Income Statement
Currency: USD
Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023
Revenue
Revenue
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
77
N/A
112
+46%
161
+43%
223
+38%
221
-1%
282
+28%
351
+24%
472
+34%
627
+33%
790
+26%
985
+25%
1 120
+14%
1 196
+7%
1 262
+6%
1 288
+2%
1 310
+2%
1 336
+2%
2 350
+76%
2 351
+0%
2 345
0%
Gross Profit
Cost of Revenue
0
0
0
0
0
0
0
0
(47)
(62)
(100)
(142)
(177)
(215)
(256)
(353)
(461)
(596)
(756)
(901)
(626)
(1 050)
(1 096)
(1 107)
(757)
(1 514)
(1 421)
(1 308)
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
30
N/A
50
+68%
61
+21%
80
+33%
44
-45%
67
+54%
95
+41%
118
+25%
166
+40%
194
+17%
229
+18%
219
-5%
570
+161%
213
-63%
192
-10%
203
+6%
579
+185%
836
+44%
930
+11%
1 036
+11%
Operating Income
Operating Expenses
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(75)
(114)
(145)
(192)
(169)
(202)
(222)
(275)
(318)
(360)
(430)
(471)
(511)
(535)
(550)
(551)
(591)
(1 022)
(1 031)
(1 024)
Selling, General & Administrative
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(68)
(93)
(125)
(163)
(138)
(163)
(176)
(216)
(258)
(293)
(354)
(391)
(426)
(436)
(443)
(438)
(476)
(813)
(816)
(809)
Depreciation & Amortization
0
0
0
0
0
0
0
0
(7)
(12)
(20)
(28)
(32)
(39)
(47)
(59)
(60)
(67)
(77)
(81)
(85)
(100)
(107)
(113)
(116)
(209)
(215)
(215)
Other Operating Expenses
0
0
0
0
0
0
0
0
0
(9)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Operating Income
(0)
N/A
(0)
-1%
(0)
+8%
(0)
+27%
(0)
-20%
(0)
-67%
(0)
-88%
(0)
-20%
(45)
-12 442%
(64)
-41%
(84)
-32%
(111)
-33%
(125)
-13%
(135)
-8%
(127)
+6%
(156)
-23%
(152)
+3%
(166)
-9%
(201)
-21%
(253)
-26%
59
N/A
(323)
N/A
(358)
-11%
(348)
+3%
(12)
+96%
(186)
-1 400%
(101)
+46%
12
N/A
Pre-Tax Income
Interest Income Expense
0
0
0
0
0
0
0
0
(3)
(5)
(8)
(12)
(15)
(22)
(29)
(32)
(25)
(36)
(45)
(66)
(80)
(97)
(88)
(87)
(71)
(130)
(140)
(141)
Non-Reccuring Items
0
0
0
0
0
0
0
0
(9)
0
8
37
98
122
148
192
203
245
314
386
(36)
499
503
467
(144)
83
(32)
(165)
Gain/Loss on Disposition of Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
0
0
(6)
(5)
(2)
(2)
5
(1)
(2)
(3)
(5)
Total Other Income
0
0
0
0
0
0
0
0
0
0
(1)
(0)
(3)
(1)
0
0
1
5
5
5
(0)
1
4
5
2
6
3
2
Pre-Tax Income
(0)
N/A
(0)
-1%
(0)
+8%
(0)
+27%
(0)
-20%
(0)
-67%
(0)
-88%
(0)
-10%
(56)
-16 941%
(69)
-22%
(85)
-23%
(87)
-2%
(46)
+47%
(36)
+22%
(8)
+78%
4
N/A
31
+636%
49
+59%
72
+48%
66
-9%
(62)
N/A
77
N/A
59
-24%
43
-28%
(226)
N/A
(228)
-1%
(272)
-19%
(296)
-8%
Net Income
Tax Provision
0
0
0
0
0
0
0
0
(6)
(4)
(12)
(18)
(24)
(39)
(44)
(58)
(88)
(105)
(134)
(176)
(152)
(186)
(189)
(170)
(151)
(278)
(274)
(267)
Income from Continuing Operations
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(62)
(73)
(97)
(105)
(70)
(74)
(52)
(53)
(57)
(56)
(62)
(110)
(215)
(109)
(130)
(128)
(377)
(506)
(547)
(563)
Income to Minority Interest
0
0
0
0
0
0
0
0
5
6
6
7
3
2
2
1
(0)
(1)
2
5
9
9
7
7
7
12
15
14
Net Income (Common)
(0)
N/A
(0)
-1%
(0)
+8%
(0)
+27%
(0)
-20%
(0)
-67%
(0)
-88%
(0)
-10%
(56)
-17 011%
(67)
-18%
(91)
-36%
(98)
-7%
(67)
+31%
(72)
-7%
(50)
+31%
(52)
-5%
(57)
-10%
(57)
+0%
(60)
-5%
(105)
-76%
(206)
-96%
(100)
+52%
(123)
-24%
(120)
+2%
(370)
-208%
(504)
-36%
(547)
-9%
(588)
-7%
EPS (Diluted)
-0.01
N/A
0
N/A
0
N/A
0
N/A
-0.01
N/A
-0.12
-1 100%
-0.04
+67%
-0.08
-100%
-0.14
-75%
-0.14
N/A
-0.19
-36%
-0.21
-11%
-0.15
+29%
-0.15
N/A
-0.1
+33%
-0.1
N/A
-0.1
N/A
-0.1
N/A
-0.1
N/A
-0.16
-60%
-0.29
-81%
-0.14
+52%
-0.17
-21%
-0.17
N/A
-0.52
-206%
-0.69
-33%
-0.75
-9%
-0.81
-8%

See Also

Discover More